Contact Us
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Lipopolysaccharide induces the interactions of breast cancer and endothelial cells via activated monocytes

Picture of Guest User Guest User Jun 6, 2022 1:09:57 PM

Oncology CTC Cellular Analysis BioFlux

ACCESS TO ARTICLE→